Skip to main content

Table 3 Major vascular complications

From: Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR)

Follow-up Total population (n = 257) SR-group(n = 148) AF-group(n = 109) p Value OR (95% CI)
30 days 9.3% (24/257) 5.4% (8/148) 14.7% (16/109) 0.016 3.01 (1.24–7.32)
3 months 9.3% (24/257) 5.4% (8/148) 14.7% (16/109) 0.016 3.01 (1.24–7.32)
6 months 9.9% (24/241) 5.8% (8/137) 15.4% (16/104) 0.016 2.98 (1.22–7.26)
12 months 10.8% (24/219) 6.3% (8/124) 16.7% (16/95) 0.017 2.95 (1.20–7.22)
  1. The table shows the major vascular complications of the total patient group and of the two groups over the course of the follow-up period. The parentheses list the number of major vascular complications and the number of patients available for analysis
  2. In patients with AF, almost three times as many major vascular complications occurred during the first 30-day post-procedural complications than in patients with SR. No further increase in major vascular complications after the first 30 days were noted, as these complications mainly occurred around the intervention